Načítá se...
Urinary angiostatin: a novel biomarker of kidney disease associated with disease severity and progression
BACKGROUND: This study aimed to evaluate the value of urinary angiostatin levels for assessing disease severity and progression of IgA nephropathy (IgAN). METHODS: Urinary angiostatin was identified as one of the distinct proteins in samples of patients with IgAN analyzed by Raybiotech protein array...
Uloženo v:
| Vydáno v: | BMC Nephrol |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6446319/ https://ncbi.nlm.nih.gov/pubmed/30943905 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12882-019-1305-2 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|